Filing Details
- Accession Number:
- 0001209191-19-009430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-12 17:33:11
- Reporting Period:
- 2019-02-12
- Accepted Time:
- 2019-02-12 17:33:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1728117 | Gossamer Bio Inc. | GOSS | Pharmaceutical Preparations (2834) | 475461709 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740847 | Bryan Giraudo | 3013 Science Park Road San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-12 | 17,879 | $0.00 | 17,879 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-02-12 | 6,000 | $16.00 | 23,879 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2019-02-12 | 57,142 | $0.00 | 12,698 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2019-02-12 | 23,316 | $0.00 | 5,181 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date.
Billionaire Hedge Funds
